- Prev close
- $302.28
- Day range
- $296.08 – $311.39
Lam Research’s 7.0% jump came alongside a strong semiconductor rebound, with the SOX rising for a fourth consecutive day and peers like AMAT +4.4%, KLAC +3.9% and TER +2.7%; the move looks sector-led and broadly supported, though the stock still trades at a rich 49.6 P/E with a beta of 1.95.
LRCX
LAM RESEARCH CORP
As of Sep 21, 2026
68/100
Worth keeping an eye onHealth ScoreWhy it moved
LRCX rose 7.0% even as the S&P 500 gained 7.0% and the Nasdaq 100 gained 7.0%, and it outperformed same-sector peers like AMAT +4.4%, KLAC +3.9%, TER +2.7% and Q +1.5%. That points to a sector-wide semiconductor rebound as the primary driver, not a broad-market move; the backdrop also fits the headlines noting the SOX rose for a fourth consecutive day.
Volatility check
This looks like a large but explainable move, not a break in fundamentals. Revenue is growing +26.0% YoY (TTM), the latest quarter was +30.0% YoY, EPS is +38.6% YoY (TTM), and margins are strong at gross +50.5%, operating +35.3% and net +31.3%. The stock is not cheap at a PE of 49.6 and forward PE of 32.2, with a PEG of 1.58 and beta of 1.95, so strong growth is already priced in and that can amplify moves in either direction; even so, the up-move is broadly consistent with the sector’s rebound rather than a purely speculative burst.
Earnings preview
The next earnings date is 2026-10-20. The facts here do not include explicit analyst revenue or EPS consensus for that print, so I can’t quote an expected growth rate or margin outlook from this period; what is available is the company’s current baseline of revenue +26.0% YoY (TTM), latest quarter +30.0% YoY, EPS +38.6% YoY (TTM), and margins of gross +50.5%, operating +35.3% and net +31.3%. The market will be focused on whether that growth pace and those margins hold, and whether demand commentary supports the current valuation of 49.6 P/E and 32.2 forward P/E.
This report is for informational and educational purposes only. It does not constitute financial, investment, tax, or legal advice. The platform does not recommend buying or selling any security.
Track LRCX with WhyIHold
Get a plain-English explanation the next time LAM RESEARCH CORP makes a big move — so you know whether it's benign or worth your attention.